Nonin Medical’s Philip Isaacson Expands CEO Role; President & COO Steve Bucholz to Retire May 1
Nonin Medical, a global leader in noninvasive medical monitoring, today announced that President and Chief Operating Officer Steve Bucholz will retire May 1. Company founder Philip Isaacson is expanding his role as Chief Executive Officer. In addition, Mr. Isaacson will continue in his role as Chief Technology Officer. Operations will transition to David Noel, Chief Financial Officer.
"Steve Bucholz has been instrumental to Nonin Medical’s growth," Mr. Isaacson said.
"Under Steve’s leadership, he assembled an extremely well qualified senior leadership team and Nonin launched a number of innovative oximetry and mHealth solutions, developed device interoperability standards, expanded its product portfolio globally and partnered with key industry leaders to further our mission of improving the quality of people’s lives. I am grateful for Steve’s 28 years of service.”
Mr. Isaacson established Nonin Medical in 1986 with three engineers; Mr. Bucholz joined the company as Operations Manager the following year. Together, they introduced the world’s first finger pulse oximeter and helped Nonin became globally recognized for its advanced signal processing and sensor design—patented technology known for providing superior monitoring performance in challenging patients and conditions.
Nonin Medical, Inc. invented the finger pulse oximeter (the original Onyx® brand) and designs and manufactures noninvasive medical monitoring solutions that meet customers’ technology needs today and tomorrow. Headquartered in Plymouth, Minn., USA, with an additional customer service center in Amsterdam, the Netherlands, Nonin Medical sells its pulse and regional oximeters, capnographs, sensors and software to health professionals and consumers in more than 125 countries. The company has more than 300 OEM partners worldwide. For more information, visit nonin.com.